Literature DB >> 19415465

Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists.

Arunima Biswas1, Sridhar Mani, Matthew R Redinbo, Matthew D Krasowski, Hao Li, Sean Ekins.   

Abstract

The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a "Jekyll and Hyde" nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415465      PMCID: PMC2846309          DOI: 10.1007/s11095-009-9901-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  132 in total

Review 1.  Rising standards for tuberculosis drug development.

Authors:  Tanjore S Balganesh; Pedro M Alzari; Stewart T Cole
Journal:  Trends Pharmacol Sci       Date:  2008-09-15       Impact factor: 14.819

Review 2.  Pregnane X receptor and its potential role in drug resistance in cancer treatment.

Authors:  Yakun Chen; Daotai Nie
Journal:  Recent Pat Anticancer Drug Discov       Date:  2009-01       Impact factor: 4.169

3.  Structural basis of human pregnane X receptor activation by the hops constituent colupulone.

Authors:  Denise G Teotico; Jason J Bischof; Li Peng; Steven A Kliewer; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

4.  Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Authors:  Vishal S Narang; Charles Fraga; Narendra Kumar; Jun Shen; Stacy Throm; Clinton F Stewart; Christopher M Waters
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-04       Impact factor: 4.249

5.  Evolution of the bile salt nuclear receptor FXR in vertebrates.

Authors:  Erica J Reschly; Ni Ai; Sean Ekins; William J Welsh; Lee R Hagey; Alan F Hofmann; Matthew D Krasowski
Journal:  J Lipid Res       Date:  2008-03-24       Impact factor: 5.922

6.  Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.

Authors:  Craig D Fisher; Jonathan P Jackson; Andrew J Lickteig; Lisa M Augustine; Nathan J Cherrington
Journal:  Arch Toxicol       Date:  2008-05-17       Impact factor: 5.153

7.  Machine learning methods and docking for predicting human pregnane X receptor activation.

Authors:  Akash Khandelwal; Matthew D Krasowski; Erica J Reschly; Michael W Sinz; Peter W Swaan; Sean Ekins
Journal:  Chem Res Toxicol       Date:  2008-06-12       Impact factor: 3.739

8.  A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine.

Authors:  Kazuto Yasuda; Aarati Ranade; Raman Venkataramanan; Stephen Strom; Jonathan Chupka; Sean Ekins; Erin Schuetz; Kenneth Bachmann
Journal:  Drug Metab Dispos       Date:  2008-05-27       Impact factor: 3.922

9.  Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

Authors:  Henriette E Meyer zu Schwabedissen; Rommel G Tirona; Cindy S Yip; Richard H Ho; Richard B Kim
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

10.  Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells.

Authors:  Suman Verma; Michelle M Tabb; Bruce Blumberg
Journal:  BMC Cancer       Date:  2009-01-05       Impact factor: 4.430

View more
  30 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

3.  A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet.

Authors:  Georges de Sousa; Ahmad Nawaz; Jean-Pierre Cravedi; Roger Rahmani
Journal:  Toxicol Sci       Date:  2014-07-15       Impact factor: 4.849

4.  SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.

Authors:  Linhao Li; Haishan Li; Brandy Garzel; Hui Yang; Tatsuya Sueyoshi; Qing Li; Yan Shu; Junran Zhang; Bingfang Hu; Scott Heyward; Timothy Moeller; Wen Xie; Masahiko Negishi; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2015-01-27       Impact factor: 4.436

5.  Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR.

Authors:  Hao Li; Matthew R Redinbo; Madhukumar Venkatesh; Sean Ekins; Anik Chaudhry; Nicolin Bloch; Abdissa Negassa; Paromita Mukherjee; Ganjam Kalpana; Sridhar Mani
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

6.  Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast database.

Authors:  Sandhya Kortagere; Matthew D Krasowski; Erica J Reschly; Madhukumar Venkatesh; Sridhar Mani; Sean Ekins
Journal:  Environ Health Perspect       Date:  2010-06-17       Impact factor: 9.031

Review 7.  Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Authors:  Terry W Moore; Christopher G Mayne; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-20

Review 8.  PXR antagonists and implication in drug metabolism.

Authors:  Sridhar Mani; Wei Dou; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 9.  Drug Mimicry: Promiscuous Receptors PXR and AhR, and Microbial Metabolite Interactions in the Intestine.

Authors:  Zdeněk Dvořák; Harry Sokol; Sridhar Mani
Journal:  Trends Pharmacol Sci       Date:  2020-10-20       Impact factor: 14.819

10.  Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR.

Authors:  Sean Ekins; Sandhya Kortagere; Manisha Iyer; Erica J Reschly; Markus A Lill; Matthew R Redinbo; Matthew D Krasowski
Journal:  PLoS Comput Biol       Date:  2009-12-11       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.